BeStock  
Stocks › TMDX

TransMedics TMDX

US equityMarket cap rank #2517
$82.99 +$3.20 (+4.00%)
Market closed · Oct 6, 4:30 am ET · Last extended-hours $82.50 -0.59%
Open$79.50
Prev close$79.80
Day range$77.37 – $83.40
Volume995.1K
Market cap$2.88B
P/E (TTM)21.5
Dividend yield–

Earnings

Average move on report day±16.1%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+51.2%
Worst reaction-29.9%

Stock move on the day after each report

-8.3%2023/Q2+51.2%2023/Q3+14.1%2023/Q4+24.9%2024/Q1-29.9%2024/Q3+5.8%2024/Q4+19.6%2025/Q1+10.5%2025/Q2+1.1%2025/Q3-4.3%2025/Q4-23.2%2026/Q1-5.3%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q24 Aug 2026After Market±15.6%-5.28%Within range
2026/Q15 May 2026After Market±12.9%-23.19%Bigger than priced
2025/Q424 Feb 2026After Market±16.0%-4.30%Within range
2025/Q329 Oct 2025After Market±17.5%+1.09%Within range
2025/Q230 Jul 2025After Market±19.0%+10.46%Within range
2025/Q18 May 2025After Market±19.3%+19.64%Bigger than priced
2024/Q427 Feb 2025After Market±27.3%+5.82%Within range
2024/Q328 Oct 2024After Market±24.8%-29.90%Bigger than priced
2024/Q130 Apr 2024After Market±18.7%+24.93%Bigger than priced
2023/Q426 Feb 2024After Market±27.5%+14.11%Within range
2023/Q36 Nov 2023After Market±20.8%+51.18%Bigger than priced
2023/Q23 Aug 2023After Market±16.8%-8.31%Within range
2023/Q11 May 2023After Market±14.5%-5.18%Within range
2022/Q422 Feb 2023After Market±17.5%+20.55%Bigger than priced
2022/Q33 Nov 2022After Market±23.6%+24.00%Bigger than priced
2022/Q21 Aug 2022After Market±16.6%-10.34%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Liver revenue$148.23M 78.1%
  • Heart revenue$37.97M 20.0%
  • Lung revenue$2.66M 1.4%
  • Service revenue unrelated to Organ Care System (OCS) transplant$1.00M 0.5%

Latest reported quarter: ANNUAL, ended Dec 2025

Revenue$605.49M+37.1% YoY
Operating profit$108.58M+189.6% YoY
Net profit$190.29M+436.6% YoY
Diluted EPS$4.87+382.2% YoY

Profitability & balance sheet

Gross margin59.9%
Operating margin17.9%
Net margin31.4%

Discussion

No comments yet — be the first to weigh in on TMDX.

Leave a comment

Scroll to Top